EUCTR2007-003706-10-FI进行中（未招募）不适用
Satunnaistettu, etenevä tutkimus keskeytyslääkkeiden annostelusta toisen raskauskolmanneksen aikaisissa keskeytyksissä
Maarit Mentula0 个研究点目标入组 200 人开始时间: 2007年10月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
A clinical Trial of Mukhakantiprada lepa and its cream on human patients of hyperpigmentation on faceCTRI/2019/05/019385Sane guruji Arogya kendra
进行中（未招募）
不适用
Estudio aleatorizado de interrrupción de tratamiento con NatalizumabRandomized Treatment Interruption of Natalizumab - RESTOREEl natalizumab es un medicamento muy eficaz utilizado en el tratamiento de pacientes con esclerosis múltiple (EM) recidivante.Se trata de un estudio prospectivo y aleatorizado, en pacientes con formas recidivantes de la EM que han recibido tratamiento con natalizumab durante un mínimo de 12 meses, sin recaídas durante ese tiempo.MedDRA version: 11Level: LLTClassification code 10063399Term: Esclerosis múltiple remitente-recurrenteEUCTR2009-017490-38-ESBiogen Idec Ltd200
进行中（未招募）
不适用
Clinical study to assess the pharmacokinetics, safety & tolerability of single and multiple oral doses of AFQ056 in children with Fragile X SyndromeEUCTR2011-004867-65-Outside-EU/EEAovartis Pharma Services AG24
进行中（未招募）
1 期
Clinical study to assess the pharmacokinetics, safety & tolerability of single and multiple oral doses of AFQ056 in children with Fragile X SyndromeEUCTR2011-004867-65-ESovartis Farmacéutica, S.A.21
进行中（未招募）
1 期
Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxicity in Chronic Hepatitis B (CHB)-infected adolescents aged 12 to <18 years in EuropeChronic Hepatitis BMedDRA version: 20.1Level: PTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-004939-39-FRGilead Sciences International Ltd.100